Table 3: Distribution of cancer indication among Category II genetic tests

Cancer # of tests % of total
Breast 7 14%
Prostate 7 14%
Lung 5 10%
Colorectal 8 16%
Pancreas 0 0%
Ovarian 11 22%
Esophagus 0 0%
Liver 1 2%
Lymphoma 0 0%
Leukemia 1 2%
Other 9 18%
Total indications 49 100%

* Total # of indications may be greater than total # of tests in the database because some tests may have multiple indications.

Return to Document